Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne Holt

Published on December 12, 2025
Sanne_holt_interview

When immuno-oncology programs fall short in translation, it is often because the models used upstream do not reflect the biology that developers ultimately care about. That gap is central to the work of Sanne Holt, Associate Director Immuno Oncology at Ncardia. Her role sits at the intersection of assay design, iPSC biology, and the operational realities of drug development.

Continue reading on website
Other news

State-of-Emergency-Proclamation-for-the-Pack-Fire-Issued-on-December-09-2025

December 11, 2025
On December 9, 2025, Governor Newsom issued a State of Emergency Proclamation for the Pack Fire, affecting Mono County. The high winds fueled the Pack Fire’s spread fires and caused serious danger to people’s lives. This caused the state to issueout evacuation orders. As of this date, Liberty Dental Plan (Liberty) has not been impacted by this incident. The Plan does not expect to have any issues

Phase appropriate GMP Across Cell Line Development Stages

December 12, 2025
Abstract As cell therapies move from research toward clinical use, the shift from exploratory science to regulated manufacturing often introduces complexity, delays, and costly rework. If GMP is not embedded from the start, the gene edited iPSC line that is meant to support the full commercial lifecycle, may fall short of regulatory expectations later on.